Showing results (11-20 of 231) with videos related to
Sort By:
Pageof 24
Expert Review of Pharmacoeconomics & Outcomes Research|November 21, 2025
Cost-effectiveness analysis of ribociclib versus palbociclib as a first line theraphy in HR+/HER2- advanced breast cancer: evidence from the Chilean public health systemC Balmaceda, N Armijo, M EspinozaCureus|July 12, 2026
Todd's Paralysis Simulating Acute Ischemic Stroke: A Case ReportPoleth G Medrano-Madrid, Edgar A Espinoza-Beltrán, Jose M Espinoza-Beltrán, et al.Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|April 10, 2007
Outcomes in children with nasolacrimal duct obstruction: Significance of persistent symptoms while stents are in placeGabriela M Espinoza, Gregg T LuederCurrent Rheumatology Reports|September 6, 2019
Orbital Vasculitides-Differential DiagnosisGabriela M Espinoza, Jessica L LiuPharmacology, Biochemistry, and Behavior|December 1, 1992
Effects of diurnal phase and pimozide on cholecystokinin-elicited hypoactivity in the hamsterP Schnur, M Espinoza, R FloresFacial Plastic Surgery Clinics of North America|October 29, 2005
Evolution of eyelid surgeryGabriela M Espinoza, John B HoldsDental Clinics of North America|June 7, 2016
Communicating with Patients with Special Health Care NeedsKimberly M Espinoza, Lisa J HeatonReports on Progress in Physics. Physical Society (Great Britain)|October 24, 2022
Pulsar glitches: observations and physical interpretationDanai Antonopoulou, Brynmor Haskell, Cristóbal M EspinozaCurrent Rheumatology Reports|July 27, 2013
Ocular vasculitisGabriela M Espinoza, Ankit Desai, Levent AkdumanNutricion Hospitalaria|August 10, 2010
[Pro-hepcidin, its relation with indicators of iron metabolism and of inflammation in patients hemodialyzed treated or not with recombinant erythropoietin]Y Barrios, M Espinoza, M A BarónPageof 24